Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Summary

Viking Therapeutics announced its intention to conduct proposed offerings of common stock and convertible senior notes. The company is a clinical-stage biopharmaceutical focused on metabolic and endocrine disorder therapies.